Kusuma Kemindo Sentosa Tbk. vs Merck Tbk. — how do they compare? Kusuma Kemindo Sentosa Tbk. trades at Rp66 (market cap 99B, 12.41M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 17.2× Kusuma Kemindo Sentosa Tbk.'s market cap, and Kusuma Kemindo Sentosa Tbk. is more actively traded (12.41M versus 37.6K). Which is the better fit depends on your goals.
| KKES | MERK | |
|---|---|---|
Market Cap | 99B | 1.7T |
Volume | 12.41M | 37.6K |
Lot | 124.07K | 376 |
Turnover | 776.84M | 144.47M |
Average Price | 62.61 | 3,842.23 |
Value | 776.84M | 144.47M |
Indicative Equilibrium Price | 66 | 3,840 |
Indicative Equilibrium Volume | 30.86K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kusuma Kemindo Sentosa Tbk (the Company) was established based on Notarial Deed No. 78 dated November 9, 1990 and amended by Deed No. 64 dated September 16, 1991, both were madebefore Notary James Herman Rahardjo, S.H., Notary in Jakarta.
Read more on KKES →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →